Tight control of cell proliferation and morphogenesis is required to ensure normal tissue patterning and prevent cancer formation. Overexpression of the ErbB-2/Neu receptor tyrosine kinase is associated with increased progression in human breast cancer, yet in breast explant cultures, the ErbB-2/Neu receptor contributes to alveolar dierentiation. To examine the consequence of deregulated ErbB-2/Neu activation on epithelial morphogenesis, we have expressed a constitutively activated mutant of ErbB-2/Neu in a Madin ± Darby canine kidney (MDCK) epithelial cell model. Using two-dimensional cultures we demonstrate that activated ErbB-2/Neu induces breakdown of cell ± cell junctions, increased cell motility and dispersal of epithelial colonies. This correlates with reorganization of the actin cytoskeleton and focal adhesions and loss of insoluble cell ± cell junction complexes involving E-cadherin. Interestingly, a constitutively activated ErbB-2/Neu receptor promotes an invasive morphogenic program in MDCK cells in a three-dimensional matrix. We show that two tyrosines in the carboxy-terminal tail of ErbB-2/Neu, involved in the phosphorylation of the Shc adapter protein, are each sucient to promote epithelial-mesenchymal like transition and enhanced cell motility in two-dimensional culture and cell invasion rather than a morphogenic response in matrix culture. This provides a model system to investigate ErbB-2/Neu induced signaling pathways required for epithelial cell dispersal and invasion versus morphogenesis. Oncogene (2001) 20, 788 ± 799.
Introduction
Breast cancer, the most frequently diagnosed cancer, is a leading cause of death in women. The development and progression of this disease to an invasive phenotype is mediated by the deregulation of dierent modulators of growth and dierentiation. Notably, several receptor tyrosine kinases that regulate growth, morphogenesis and dierentiation of the breast epithelium are associated with the development and progression of breast cancer. Among these tyrosine kinases, ErbB-2/HER-2/Neu (Pegram et al., 1998) and Met, the Hepatocyte growth factor/Scatter factor (HGF/SF) receptor (Ghoussoub et al., 1998; Yamashita et al., 1994) are prognostic markers for breast cancer. The ampli®cation and overexpression of ErbB-2 is associated with increased progression and metastasis of 25 per cent of human breast carcinomas and is indicative of poor prognosis in breast, ovarian, and renal collecting duct carcinomas (Pegram et al., 1998; Selli et al., 1997; Zhang et al., 1997) . Consistent with this, overexpression of a wild type or constitutively activated ErbB-2/neu transgene in the mammary epithelia of mice induces the formation of metastatic mammary tumors (Muller et al., 1988) . In contrast, the Met and ErbB-2 receptor tyrosine kinases are also associated with the morphogenic and functional dierentiation of the normal mammary gland epithelium. Whole organ cultures and cell culture models suggest a requirement for Met for tubulogenesis of the breast epithelium and ErbB-2 for lobuloalveolar dierentiation (Yang et al., 1995) .
The development of invasive cancers correlates with a shift from an organized epithelia towards cells with a ®broblast-like mesenchymal phenotype, referred to as epithelial-mesenchymal transition (EMT) (Boyer et al., 1996) . In some breast tumor cell lines, ErbB-2 enhances cell migration and invasion in response to neuregulins or heregulin, ligands that indirectly activate ErbB-2 (Meiners et al., 1998; Brandt et al., 1999) , whereas in others, activation of ErbB-2 promotes a remodeling of epithelial cell junctions consistent with a morphogenic response (Chausovsky et al., 1998) . Hence the biological consequence of an ErbB-2 activation signal to promote epithelial cell dispersal versus reorganization, may depend on signals altered in the various tumor cells assayed. Although several studies have addressed the molecular mechanism through which this receptor transforms ®broblasts and induces tumors in transgenic animals (Dankort et al., 1997; Guy et al., 1992 Guy et al., , 1996 , no studies have examined the ErbB-2 initiated signal transduction events required for epithelial cell dispersal versus morphogenesis.
Activation of receptor tyrosine kinases by their ligand promotes receptor homo-or heterodimerization and transphosphorylation of the receptor on tyrosine residues that provide speci®c binding sites for signaling proteins (reviewed in Weiss and Schlessinger, 1998; Pawson and Nash, 2000) . Although this event is normally tightly regulated, receptor overexpression can promote receptor clustering and activation in the absence of ligand. To address the functional signi®cance of speci®c ErbB-2/Neu initiated signals in epithelial cell dispersal and morphogenesis we have utilized a series of activated Neu receptor mutants. Mutant receptors either lack all known carboxy-terminal tyrosine phosphorylation sites, where ®ve tyrosine residues are substituted for nonphosphorylated phenylalanine residues, or possess only one of these tyrosine phosphorylation sites in isolation (Dankort et al., 1997) .
To date HGF and its receptor Met are one of the most potent inducers of EMT known. This has been extensively studied using a Madin ± Darby Canine kidney (MDCK) renal epithelial cell model, where HGF activation of the Met tyrosine kinase receptor promotes EMT in two-dimensional culture and branching morphogenesis in three-dimensional matrix culture (Royal and Park, 1995; Zhu et al., 1994; Weidner et al., 1993) . We have used the MDCK epithelial cell model for structure ± function studies to examine the role of ErbB-2/Neu signals involved in epithelial cell dispersal versus a morphogenic program, and the consequence of deregulated ErbB-2 activation. We show that a constitutively activated Neu receptor induces EM-like transition of MDCK cells in twodimensional culture but promotes a morphogenic invasive program in three-dimensional matrix culture. Using a series of activated Neu substrate binding mutants, we show that three tyrosines in the carboxyterminal tail of Neu are each sucient to promote EMlike transition and enhanced cell motility. Two of these, involved in the phosphorylation of the Shc adapter protein, also promote a partial morphogenic program. This provides a model system to investigate ErbB-2/Neu induced signaling pathways required for epithelial cell dispersal and morphogenesis.
Results

Activated ErbB-2/Neu induces dispersal of MDCK cells
To examine the consequence of deregulated ErbB-2/ Neu activation in epithelial tissues, we have generated MDCK epithelial cell lines stably expressing wild type (WTNeu) as well as mutant Neu receptors (Figure 1) . A constitutively activated Neu mutant (NT) carries a point mutation in the transmembrane domain (V664E) resulting in increased receptor homodimerization and constitutive activation of the kinase domain in the absence of ligand (Bargmann et al., 1986) . Mutation of the ®ve carboxy-terminal tyrosine residues of the NT mutant into phenylalanine results in a Neu Tyrosine Phosphorylation-De®cient (NYPD) mutant, which is kinase active but has an impaired ability to transform Rat1 ®broblasts (Dankort et al., 1997) . Add-back mutants were generated by reverting individual phenylalanine substitutions to tyrosine residues, allowing association with distinct signaling molecules ( Figure 1a) . The resulting mutants YB, YC, YD and YE exhibit transformation of ®broblasts to a comparable level as the activated NT receptor whereas it is believed that site A acts as a negative regulatory site for Neu (Dankort et al., 1997) . All of these mutant receptors are tyrosine phosphorylated and catalytically active (Dankort et al., 1997; Figure 1b) .
We show that expression of NT in MDCK cells induces morphological changes, breakdown of cellular junctions and cell dispersal, in a similar manner to HGF-stimulated cell scatter (Figure 2 ). The observed morphological changes are characteristic of epithelialmesenchymal transition (EMT). In contrast, MDCK cells expressing WTNeu exhibit an epithelial morphology, comparable to the parental MDCK cell line (tight colonies), whereas the NYPD, YA and YB-expressing cells grow as colonies of¯attened cells (Figure 2 ). In contrast, add-back mutants YC, YD and YE induce dispersed cells that have a similar morphology, albeit less scattered, to cells expressing NT, suggesting that signaling pathways downstream from these tyrosine residues are sucient for the NT-induced morphological changes.
Activated ErbB-2/Neu induces breakdown of adherens junctions and cytoskeletal reorganisation of MDCK epithelial cells E-cadherin is involved in promoting and maintaining cell-cell adhesion through the formation of adherens junctions that contain b-catenin. Breakdown of these contacts is a prerequisite for cell dissociation. We and others have shown that HGF stimulation of MDCK cells disrupts adherens junctions and induces the redistribution of E-cadherin into a cytoplasmic soluble compartment (Royal and Park, 1995; and Figure 3) . To examine the consequence of Neu expression on cellcell junctional complexes we examined the localization of E-cadherin and b-catenin by indirect immunohistochemistry. Whereas E-cadherin and b-catenin are localised at the membrane at cell ± cell contacts in parental MDCK cells, or in cells expressing WT, NYPD, YA or YB mutants (Figure 3a and data not shown), MDCK cells expressing NT, YC, YD and YE show loss of insoluble E-cadherin staining at cell ± cell contacts but retain b-catenin staining when cells are in contact. This is consistent with reduced levels of Ecadherin but not b-catenin in an NP40-insoluble fraction ( Figure 3a,d and data not shown), although the steady-state levels of E-cadherin and b-catenin are not altered (Figure 3e and data not shown).
To establish the nature of the cytoskeletal reorganisation induced by the expression of Neu-NT, we have used indirect immuno¯uorescence with TRITC-labeled phalloidin to detect polymerized actin and vinculin to visualize focal adhesion complexes. We show by immuno¯uorescence that NT induces the loss of cortical actin at cell ± cell junctions and the formation of actin stress ®bers localized in lamellipodial-like structures (Figure 3c ). In addition, vinculin staining reveals the redistribution of focal adhesions from the periphery of the colony into larger complexes throughout the surface of NT-expressing cells (Figure 3c ). Mutants YC, YD and YE show a similar pattern (data not shown), whereas cells expressing WTNeu resemble MDCK cells (Figure 3c ). The NYPD, YA and YB mutants show increased large vinculin-containing complexes and actin stress ®bers, consistent with the increased spreading of cells expressing these mutants (Figure 3c and data not shown).
Activated ErbB-2/Neu increases spontaneous motility of epithelial cells
Cell dispersal involves the disruption of cellular adhesion complexes, reorganization of the actin cytoskeleton and formation of membrane extensions (reviewed in Sheetz et al., 1999; Mitchison and Cramer, 1996) . Therefore, the observed cytoskeletal changes in NT-expressing cells suggest that cells have adopted a ®broblastic-like morphology with increased motility following NT expression. To establish this we have used modi®ed boyden chambers where the ability of cells to migrate across the ®lter can be quantitated. We show that expression of NT increases spontaneous cell motility by 10-fold when compared to parental MDCK cells, and is comparable to the HGF-induced increase in MDCK cell motility (Figure 4a,b) . These results Figure 4b ). This suggests that an activated Neu kinase can enhance cell motility through a mechanism independent from substrate association with the YA-E tyrosine residues.
Activated ErbB-2/Neu induces branching tubulogenesis in MDCK epithelial cells
We have shown previously that the tyrosine kinase activity of the Met receptor is required to induce branching morphogenesis, and that EGF fails to induce tubulogenesis of MDCK cells cultured in a three-dimensional collagen matrix, although these cells express the EGF receptor (Zhu et al., 1994; Maroun et al., 1999; and Figure 5d ). Interestingly, NeuNTexpressing MDCK cells spontaneously form tubules when seeded in a collagen matrix (Figure 5a ,b). Tubules induced by NeuNT are composed of a single layer of epithelial cells, surrounding a hollow interior (Figure 5c ), and resemble HGF-induced branching tubules ( Figure 5 ; Fournier et al., 1996) . In contrast the expression of the NYPD, YA, YB and YC mutants promoted the formation of large cysts that contain a single layer of epithelium with a hollow interior ( Figure  5a ,b,c and data not shown). Expression of the YD and YE mutants induced the formation of various structures, ranging from spikes to unbranched hollow tubules containing organized epithelium, but at reduced eciency when compared with cells expressing the NT mutant ( Figure 5a ,c, Table 1 ). Overexpression of WTNeu did not induce a morphogenic program (Figure 5a ), neither did stimulation of corresponding cells with either EGF or heregulin, a ligand for ErbB family receptors, whereas in these cells HGF induced ecient branching tubules (Figure 5d ). Instead, the formation of large cysts was observed in response to heregulin when compared to control cells (Figure 5d ). These results suggest that signaling downstream from a constitutively activated ErbB-2/Neu is sucient for the induction of a morphogenic invasive response, but that the Neu YD and YE mutants are insucient for a full morphogenic response.
MEK dependent signaling pathways are crucial for ErbB-2/Neu induced epithelial dispersal
We and others have previously shown that the breakdown of epithelial cell ± cell junctions in response to HGF requires PI3K, MEK, Ras and Rho family dependent signals (Royal and Park, 1995; Potempa and Ridley, 1998; Royal et al., 2000; and Figure 6a) . Pharmacological inhibitors of PI3K (LY294002, 20 ± 50 mM) and the MAPK Kinase, MEK (PD98059, 50 mM) were used to establish the requirements of these pathways in the Neu-NT-induced dispersal of epithelial cells. Treatment of cells with the PI3K inhibitor, LY294002, partially reverses Neu-NT-induced cell dispersal. In the presence of LY294002 NT-expressing cells still show extensive spreading, lack cortical actin and show a partial redistribution of Ecadherin and b-catenin to cell ± cell junctions, although under similar conditions LY294002 blocks HGFinduced cell dispersal ( Figure 6 ). A similar pattern of inhibition was obtained with the YC, YD and YE mutants (data not shown). In contrast treatment of Neu-NT-expressing cells with PD98059 reverses this process. In the presence of PD98059, cells reform extensive cortical actin and show reorganization of focal adhesion complexes and relocalisation of insoluble E-cadherin and b-catenin to cell ± cell junctions in a similar manner to parental MDCK cells (Figures 3a, b and 6b) . The YB and YD mutants were previously shown to bind Grb2 and Shc, an upstream activator of Ras and MEK (Dankort et al., 1997) . Immunoprecipitation of Shc and immunoblotting with antiphosphotyrosine sera, shows an increase in Shc phosphorylation predominantly in NT, YD and YEexpressing cells and to a lesser extent in YC-expressing cells (Figure 7 ). Previous data have suggested that when compared with other receptor tyrosine kinases only the Met receptor promotes tubulogenesis of MDCK cells in collagen (Sachs et al., 1996; Maroun et al., 1999) . To establish whether NT-induced scatter and tubulogenesis of MDCK cells is mediated through an enhancement of Met activation by an activated Neu receptor, we have examined Met phosphorylation. Although a baseline level of Met phosphorylation was detected, no detectable changes in Met phosphorylation levels were observed in Neu-expressing MDCK cells (Figure 8 , data not shown). Moreover, conditioned medium collected from NT expressing cells was unable to induce scatter of MDCK cells (data not shown), whereas conditioned medium from MRC5 cells that secrete HGF, induced ecient cell scatter. Taken together, our data suggest that activated Neu induces tubulogenesis and cell dispersal through a Met independent mechanism.
Discussion
Epithelial-mesenchymal transition (EMT) is characterized by the conversion of epithelial cells into ®broblast- (Boyer et al., 1996; Meiners et al., 1998) . ErbB-2/Neu ampli®cation and overexpression has been implicated in the etiology of breast and ovarian carcinomas and correlates with poor clinical prognosis (Pegram et al., 1998) . Several studies have addressed the requirement for speci®c ErbB-2 dependent signals in cell transformation and tumorigenesis in animal models, however no studies have addressed these requirements for EMT. Here we demonstrate that activated ErbB-2/Neu promotes an EM-like transition with breakdown of cell ± cell junctions, dispersal of epithelial colonies and enhanced cell motility, but promotes a morphogenic program when these cells are placed in a three-dimensional matrix. Using receptor mutants we show that three independent tyrosine autophosphorylation sites on the ErbB-2/ Neu protein, YC, YD and YE, induce an EM-like transition and cell dispersal, two of these, YD and YE, promote invasive growth but are insucient for the full morphogenic response.
Many processes are involved in epithelial cell dispersal and cell motility. These include reorganization of the actin cytoskeleton and turnover of focal contacts, breakdown of cellular junctions to allow cell dissociation, and the formation of membrane extensions allowing cells to attach to the extracellular matrix. In a similar manner to HGF-induced EMT, (Royal and Park, 1995; Potempa and Ridley, 1998; Royal et al., 2000) , we show that activated ErbB-2/Neu promotes epithelial cell dispersal. This supports observations that a chimeric Trk-ErbB-2 receptor can induce partial dispersal of MDCK cells, although these cells were not analysed in detail (Sachs et al., 1996) . By indirect immuno¯uorescence, cells expressing activated ErbB-2/Neu NT show loss of cortical actin and the formation of bundled actin stress ®bers, as well as loss of peripheral vinculin-containing focal complexes and the appearance of large intracellular focal contacts (Figure 3 ). Consistent with their dispersed phenotype, extensive membrane extensions and lamellipodia are visible in NT-expressing cells (Figure 3 ) and these cells show enhanced cell motility in Transwell assays, comparable to cells stimulated with HGF (Figure 4) . These data are similar to the cytoskeletal changes and enhanced cell motility observed following stimulation of some breast cancer cell lines with heregulin, a ligand (Chausovsky et al., 1998; Adam et al., 1998; Meiners et al., 1998) . However many breast tumor cell lines lack functional adherens junctions through genetic alterations that lead to loss of expression of E-cadherin (Ji et al., 1997) and a role for Her2/Neu in the breakdown of epithelial junctions had not been addressed.
Importantly, the expression of NT promotes the disruption of stable adherens junctions in MDCK cells, as shown by the loss of insoluble E-cadherin at cell ± cell junctions and a redistribution of insoluble bcatenin in NT-expressing cells (Figure 3 ). This is similar to HGF stimulation of MDCK cells, which induces the relocalization of E-cadherin into a cytoplasmic soluble compartment (Royal and Park, 1995; Potempa and Ridley, 1998) . However, in contrast to D'Souza and Taylor-Papadimitriou, 1994, who reported the transcriptional downmodulation of Ecadherin in an immortalized human mammary epithelial cell line overexpressing wild type ErbB-2, the steady-state levels of E-cadherin and b-catenin remain unaltered following expression of activated ErbB-2/ Neu in MDCK cells (Figure 3e) . Moreover, when NeuNT-expressing cells are in contact, E-cadherin and b-catenin localize at cell ± cell contacts in insoluble complexes indicating that junctional complexes can form and that an irreversible epithelial ± mesenchymal transition has not occurred (Figure 3a,b) .
Our structure ± function analyses using add-back mutants of ErbB-2/Neu demonstrated that the YC, YD or YE sites were each sucient to promote EMlike transition as well as enhanced cell motility ( Figures  2 and 4) . The YD and YE sites were previously shown to interact with the Shc adapter protein (Dankort et al., 1997; Ricci et al., 1995) . Consistent with this, Shc phosphorylation was elevated in cells expressing the activated NT or the YD or YE mutants and to a lesser extent in cells expressing the YC mutant, but was not elevated in cells expressing mutants that fail to induce cell dispersal (YA and YB, Figures 2 and 7) . Similarly the recruitment of Shc to the Met/HGF receptor is required for full cell dispersal in response to HGF MDCK cells grown in a collagen matrix were stimulated with EGF and heregulin a1 at 20 ng/ml and 100 ng/ml respectively. Picture magni®cation: 106. *`Tubules' are structures whose length is ®ve times their diameter. Structures' represents any structure that does not belong to the`Cysts' or`Tubules' categories, it includes spikes, unbranched tubules, protrusions as well as dispersed structures Activated ErbB-2/Neu induces EM-like transition in MDCK cells H Khoury et al (Fournier et al., 1996) and Shc overexpression enhances motility of MDCK cells . Moreover, using pharmacological inhibitors, we demonstrated that MEK activation is required for the maintenance of Neu-induced cell dispersal and related cytoskeletal and junctional alterations ( Figure  6 ). Importantly, treatment of cells with a MEK inhibitor (PD98059), reverses the phenotypic EM-like transition induced by activated Neu, and promotes the reformation of cortical actin and the redistribution of E-cadherin and b-catenin to cellular junctions ( Figure  6b ). This is consistent with a requirement for MEK activity for HGF-induced breakdown of epithelial cell junctions (Potempa and Ridley, 1998) , but indicates in addition that MEK activity is required to maintain loss of E-cadherin dependent junctional complexes. Importantly, many breast cancers exhibit elevated activity of ERK 1 and 2, downstream targets of MEK, and role for MAPK was implicated in cell motility through its ability to phosphorylate myosin light chain kinase and enhance cell contractility (Klemke et al., 1997) . The Neu YB add-back mutant, which recruits Grb2, and was shown to promote transformation of ®bro-blasts in a Ras-dependent manner (Dankort et al., 1997) is unable to promote the breakdown of cell ± cell junctions, although it enhances cell motility when a single cell suspension is seeded in a Transwell migration assay (Figures 2 and 4) . This may re¯ect that signals from Shc, distinct from Grb2 (RozakisAdcock et al., 1992) are important for breakdown of cell junctions or that additional unknown signaling proteins are recruited to the YD, YE or YC sites. In contrast to the MEK inhibitor, the PI3K inhibitor, LY294002, does not promote a reversal of the EMT-like phenotype of NT-expressing cells ( Figure   6 ). Although treatment of NT-expressing cells with LY294002 inhibited the formation of membrane extensions, cells failed to form extensive E-cadherin containing cell ± cell junctions or cortical actin ( Figure  6 ). Hence, although PI3K activity is required for the breakdown of cell ± cell junctions in response to HGF (Royal and Park, 1995; Royal et al., 2000; Potempa and Ridley, 1998; Khwaja et al., 1998) , once epithelial cells are dispersed in response to activated Neu, a PI3K-dependent signal is not required to inhibit junction formation. However a PI3K-dependent signal is required for the formation of lamellipodia in the dispersed NT-expressing cells. This is consistent with a requirement for PI3K activity for the activation of the small GTPase Rac and for PAK1, a direct target for activated Rac, both of which are involved in HGFinduced lamellipodia formation (Royal et al., 2000) . Adam et al. (1998) have shown that PAK1 is activated in a PI3K-dependent manner downstream of ErbB-2 in MCF7 cells, suggesting a role for PAK in the cytoskeletal actin reorganization and increased cell motility.
Whereas MDCK cells expressing activated Neu scatter in two-dimensional culture, when seeded in a collagen matrix these cells undergo an invasive morphogenic program and form tubule-like structures with organised epithelia and a lumen in a similar manner to HGF-stimulated MDCK cells ( Figure 5 ). Cells expressing the YD and YE mutants that couple with and/or induce phosphorylation of Shc, form some tubular structures, however many dissociated cells are observed, consistent with loss of epithelial organization and invasion of single cells into the surrounding matrix ( Figure 5 ). This may re¯ect the inability of the YD and YE mutants to activate Neu-dependent signaling pathways required for a full morphogenic response. Consistent with this, transgenic mice expressing the Shc binding NeuYD receptor to mammary epithelium, induce mammary tumors with rapid onset (Dankort and Muller, unpublished) . However, transgenic mice expressing elevated levels of Shc in the mammary epithelium, exhibit extensive branching and alveolar development of the breast epithelium (Rauh et al., 1999) , which supports a role for Shc dependent signals in epithelial morphogenesis. In addition, in MDCK cells and in murine`knock in' models, Grb2-dependent signaling pathways are required for a morphogenic response downstream from the Met receptor (Fournier et al., 1996; Maroun et al., 1999; Maina et al., 1996) . Interestingly the YB mutant, which couples with Grb2, is insucient to induce an invasive morphogenic response required for the formation of branching tubules, and instead maintains an organized epithelium and promotes cyst expansion, consistent with its inability to promote dispersal of epithelia in twodimensional cultures (Figure 2 and 5) .
To date Met was the only receptor capable of inducing a branching tubulogenic program in MDCK cells, and previous studies using a chimeric Trk-ErbB2 receptor failed to induce tubulogenesis in response to stimulation (Sachs et al., 1996) . This may re¯ect the Figure 5 and Maroun et al., 1999) . Consistent with this, heregulin is unable to promote tubule formation in MDCK cells overexpressing WTNeu ( Figure 5 ), but rather promotes an enlargement of the cyst in a similar manner to cells expressing the YB mutant. This may be consistent with the ability of heregulin to promote alveologenesis in breast epithelium (Niemann et al., 1998; Yang et al., 1995) and is not inconsistent with a requirement for Grb2-dependent signals for a morphogenic response. In this respect the observation that an activated Neu receptor promotes a tubulogenic response whereas the YD and YE mutants promote a more invasive response may re¯ect the possibility that the YBGrb2 binding site may enhance or stabilize a morphogenic response induced by the YD or YE add-back mutants. Alternatively, an NT receptor may also recruit negative regulatory proteins that modulate the signal in response to receptor activation. For example Cbl, a ubiquitin ligase targets ErbB-2 to a ubiquitin/degradation pathway (Klapper et al., 2000) . Together these data demonstrate that a constitutive ErbB-2/Neu signal is sucient to induce the breakdown of epithelial junctions and cell dispersal of highly dierentiated and nontumorigenic epithelial cells supporting a role for ErbB2 in the epithelial mesenchymal transition and dispersal of human cancers. 
Materials and methods
Antibodies and reagents
Antibodies used in this paper are: mouse anti-Neu antibodies Ab-3 and Ab-4 (Oncogene Research Products, Cambridge, MA, USA), mouse anti-phosphotyrosine (4G10) (Upstate Biotechnology Inc., Lake Placid, NY, USA), mouse anti-Ecadherin and mouse anti-b-catenin (Transduction Labora- Cell culture MDCK cells were maintained in Dulbecco's modi®ed Eagle's medium containing 10% fetal bovine serum and 50 mg/ml gentamycin (Gibco ± BRL). Neu mutants (Dankort et al., 1997) were transfected into MDCK cells by the calcium phosphate method, stable cell lines were selected in G418 (400 mg/ml) (Geneticin, Gibco ± BRL). 5610 3 cells were seeded in 24-well dishes (Nunc) for scatter and immuno¯uorescence studies. After 48 h, HGF, LY294002 and PD98059 were added to the medium at 5 U/ ml, 20 ± 50 mM and 20 ± 50 mM respectively, for 24 h.
Motility assay
Cells (5610 5 /well) were plated on Transwell ®lters (Costar). Twenty-four hours later, ®lters were submerged in formalin phosphate buer (Fisher) for 15 min, washed twice with distilled water, and stained with crystal violet for 15 min at room temperature followed by several washes with water. Non-migrating cells were scraped o the upper layer of the ®lter using a cotton swab. Filters were then air-dried and photographs were taken. To quantitate the rate of migration for each cell line, ®lters were cut, solubilized in 10% acetic acid, and absorbance readings taken at 596 nm. The results plotted are average numbers of four experiments for each cell line.
Tubulogenesis assay
MDCK cells were suspended in a collagen matrix as described previously (Maroun et al., 1999) . HGF (5 U/ml), EGF (20 ng/ml) and heregulin (20 and 100 ng/ml) were added to the medium at day 5 where applicable. Quantitation of the morphogenic response was performed as described in Maroun et al. (1999) .
Immunoprecipitation and Western blotting
Cells were seeded at 10 6 /100-mm dish (Nunc). The next day, cells were washed once with DMEM and serum-starved for 24 h in DMEM containing 0.02% FBS. Cells were then washed once with PBS before they were lysed in Triton X-100 lysis buer (50 mM HEPES pH 7.4, 150 mM NaCl, 10% glycerol, 0.5% Triton, 1 mM phenylmethylsulfonyl¯uoride, 1 mg/ml of leupeptin and aprotinin, 1 mM Na 3 VO 4 ). Alternatively, RIPA lysis buer was used (50 mM Tris-Cl pH 7.5, 150 mM NaCl, 1% Nonidet P-40 (NP-40), 0.1% SDS, 0.5% sodium deoxycholate, 1 mM phenylmethylsulfonyl¯uoride, Figure 8 ErbB2/Neu expression does not induce phosphorylation of the Met receptor in MDCK cells. Triton X-100 cell lysates (1 mg) were immunoprecipitated by various antibodies as indicated and the proteins separated on an 8% SDS-polyacrylamide gel. Following transfer to nitrocellulose, membranes were probed with anti-phosphotyrosine (4G10), anti-Neu (Ab-3) or rabbit anti-Met (Ab144) Figure 7 Neu-induced cell scatter and tubulogenesis correlate with increased phosphorylation of the Shc adaptor protein.
Proteins were immunoprecipitated from Triton X-100 cell lysates (1 mg) with rabbit anti-Shc, separated on a 10% SDS-polyacrylamide gel and immunoblotted with anti-phosphorytosine (4G10), stripped then reprobed with anti-Shc 1 mg/ml of leupeptin and aprotinin, 1 mM Na 3 VO 4 ). Equal amounts of total protein were immunoprecipitated, separated by electrophoresis on 8% SDS-polyacrylamide gels, transferred to a nitrocellulose membrane and immunoblotted as described previously (Maroun et al., 1999) . NP-40 soluble and insoluble fractions were prepared and electrophoresed as described previously (Potempa and Ridley, 1998) .
Immunofluorescence microscopy
Cells grown on glass coverslips (Bellco Glass, Vineland, NJ, USA) were ®xed in 3.7% formaldehyde for 10 min and permeabilized in PBS containing 0.2% Triton X-100 and 5% FBS for 5 min at room temperature. Cells were then incubated with anti-E-cadherin (1 : 200) for 30 min, washed in PBS, then incubated in the presence of Alexa 488-labeled anti-mouse (1 : 1000) and TRITC-labeled phalloidin (1 : 1000) for 15 min. Phalloidin was used to visualize polymerized actin. For b-catenin and vinculin staining, cells were treated for 5 min with CSK lysis buer (10 mM PIPES buer, pH 7.0, 300 mM sucrose, 50 mM NaCl, 3 mM MgCl 2 , 0.5% Triton X-100) prior to ®xation. Coverslips were mounted onto slides in Immuno-Fluore medium (ICN, St-Laurent, QC), and images were photographed using a BioRad confocal microscope (Hercules, CA, USA).
Thin layer microscopy
Collagen cultures were ®xed and sectioned as described earlier (Fournier et al., 1996) . Photographs were taken using a digital image processing system (Northern Eclipse, Empix Imaging Inc., Toronto, ON) at a magni®cation of 326.
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